These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19117047)

  • 1. Screening of heparin API by near infrared reflectance and Raman spectroscopy.
    Spencer JA; Kauffman JF; Reepmeyer JC; Gryniewicz CM; Ye W; Toler DY; Buhse LF; Westenberger BJ
    J Pharm Sci; 2009 Oct; 98(10):3540-7. PubMed ID: 19117047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
    Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and characterization of heparin impurities.
    Beni S; Limtiaco JF; Larive CK
    Anal Bioanal Chem; 2011 Jan; 399(2):527-39. PubMed ID: 20814668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
    Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
    Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
    Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of currently marketed heparin products: key tests for quality assurance.
    Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
    Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
    Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
    Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
    Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
    J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
    Wielgos T; Havel K; Ivanova N; Weinberger R
    J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
    Volpi N; Maccari F; Linhardt RJ
    Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
    Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
    J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of circular dichroism as a simple heparin-screening strategy.
    Stanley FE; Stalcup AM
    Anal Bioanal Chem; 2011 Jan; 399(2):701-6. PubMed ID: 20953771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm.
    Lee SE; Chess EK; Rabinow B; Ray GJ; Szabo CM; Melnick B; Miller RL; Nair LM; Moore EG
    Anal Bioanal Chem; 2011 Jan; 399(2):651-62. PubMed ID: 20949261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
    Li H; Wickramasekara S; Nemes P
    Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and highly sensitive mixed-polymeric electrokinetic chromatography system for determination of contaminants and impurities of heparin samples.
    Tripodi V; Flor S; Dobrecky C; Contin M; Lucangioli S
    Electrophoresis; 2010 Oct; 31(21):3606-12. PubMed ID: 20967770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.